0001811288-23-000001.txt : 20230929 0001811288-23-000001.hdr.sgml : 20230929 20230929145205 ACCESSION NUMBER: 0001811288-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230929 DATE AS OF CHANGE: 20230929 EFFECTIVENESS DATE: 20230929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evozyne, Inc. CENTRAL INDEX KEY: 0001811288 IRS NUMBER: 844576299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493466 FILM NUMBER: 231294890 BUSINESS ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-847-1322 MAIL ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Evozyne, LLC DATE OF NAME CHANGE: 20200506 FORMER COMPANY: FORMER CONFORMED NAME: Evozyne LLC DATE OF NAME CHANGE: 20200504 D 1 primary_doc.xml X0708 D LIVE 0001811288 Evozyne, Inc. 330 N. WABASH AVENUE SUITE 3500 CHICAGO IL ILLINOIS 60611 312-847-1322 DELAWARE Evozyne, LLC Evozyne LLC Corporation true 2019 Patrick J. Morris 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Executive Vice President, Legal Affairs, Assistant Secretary, and Director Rama Ranganathan 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Chief Scientific Officer and Director Aris Theologis 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Chief Business Officer Jeffrey S. Aronin 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Chairman and Director Darien Parhad 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Chief Financial Officer and Treasurer Antonio Gracias 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Director Director Mike Gamson 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director President, Chief Executive Officer, and Director Arjun Rallapalli 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Chief Operating Officer Jude M. Sullivan 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer General Counsel and Secretary Aleina Lee 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Corporate Controller Matthew Rizzo 330 N. Wabash Ave. Suite 3500 Chicago IL ILLINOIS 60611 Director Director Biotechnology Decline to Disclose 06b false 2023-09-14 false true true false 0 Paragon Health Capital, LLC 300729 None None 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 IL ILLINOIS MA MASSACHUSETTS FL FLORIDA NY NEW YORK CA CALIFORNIA false 100000001 81000122 18999879 Total sold includes sale of secured conv promissory notes amounting to $40500061 in aggregate. Total Remaining includes approx $9,499,940 of remaining equity to be sold & approx $9499940 of remaining secured convertible promissory notes to be sold. false 29 2046080 0 0 false Evozyne, Inc. /s/ Jude Sullivan Jude Sullivan General Counsel and Secretary 2023-09-29